Is the FDA Pausing More Cancer Trials? It's Hard to Tell
Medscape,
In October, the US Food and Drug Administration (FDA) pressed pause on a trial studying a new lymphoma drug after a patient died.
In October, the US Food and Drug Administration (FDA) pressed pause on a trial studying a new lymphoma drug after a patient died.
Whoever President Joe Biden picks to lead the Food and Drug Administration will face a daunting challenge: rebuilding an agency…
All of us desperately await the day when we can send our children to school, spend time with our grandparents and grandkids…